Jump to content

Patent application for antiviral drug Favipiravir rejected by Thai officials


Thaiger
 Share

Recommended Posts

The patent application for the Japanese antiviral drug Favipiravir used to treat Covid-19 has been rejected in Thailand. With thousands of Covid-19 patients in hospitals and field hospitals, the Thai government made emergency orders for the drug, and sought permission for the right to produce the medicine locally. An application had been filed under the compulsory license system where the government allows a company to produce a patented product in an emergency and for non-commercial use. The application was rejected by Thailand’s Intellectual Property Department and the department’s director general says it failed to meet the requirements for registration, according to […]

The post Patent application for antiviral drug Favipiravir rejected by Thai officials appeared first on Thaiger News.

Read the full story

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

 Share

×
×
  • Create New...

Important Information

By posting on Thaiger Talk you agree to the Terms of Use